| Primary |
| Osteoporosis Postmenopausal |
48.3% |
| Product Used For Unknown Indication |
21.3% |
| Osteoporosis |
19.0% |
| Hypertension |
2.9% |
| Pain |
1.3% |
| Osteopenia |
1.1% |
| Rheumatoid Arthritis |
1.0% |
| Hypothyroidism |
0.7% |
| Gastrooesophageal Reflux Disease |
0.6% |
| Senile Osteoporosis |
0.6% |
| Bone Loss |
0.4% |
| Asthma |
0.4% |
| Depression |
0.4% |
| Hyperlipidaemia |
0.4% |
| Breast Cancer |
0.4% |
| Back Pain |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Hypercholesterolaemia |
0.3% |
| Prostate Cancer |
0.3% |
| Diabetes Mellitus |
0.3% |
|
| Death |
16.9% |
| Pain In Extremity |
10.3% |
| Rash |
8.1% |
| Osteonecrosis Of Jaw |
6.6% |
| Pain |
6.2% |
| Back Pain |
5.7% |
| Tooth Disorder |
4.6% |
| Hypocalcaemia |
4.5% |
| Myalgia |
4.4% |
| Urinary Tract Infection |
4.3% |
| Pain In Jaw |
4.1% |
| Arthralgia |
4.1% |
| Bone Pain |
3.6% |
| Pruritus |
3.1% |
| Muscle Spasms |
2.4% |
| Nausea |
2.3% |
| Toothache |
2.3% |
| Malaise |
2.2% |
| Paraesthesia |
2.2% |
| Urticaria |
2.1% |
|
| Secondary |
| Osteoporosis Postmenopausal |
36.0% |
| Osteoporosis |
22.0% |
| Product Used For Unknown Indication |
12.6% |
| Hypertension |
5.8% |
| Osteopenia |
4.8% |
| Rheumatoid Arthritis |
4.2% |
| Pain |
1.9% |
| Senile Osteoporosis |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Hypothyroidism |
1.3% |
| Hyperlipidaemia |
1.0% |
| Hypersensitivity |
1.0% |
| Breast Cancer |
0.9% |
| Breast Cancer Female |
0.8% |
| Metastases To Bone |
0.8% |
| Osteoarthritis |
0.8% |
| Prostate Cancer |
0.8% |
| Systemic Lupus Erythematosus |
0.8% |
| Anxiety |
0.7% |
| Atrial Fibrillation |
0.7% |
|
| Pain In Extremity |
11.9% |
| Osteonecrosis Of Jaw |
8.6% |
| Death |
8.2% |
| Rash |
7.4% |
| Back Pain |
6.1% |
| Tooth Disorder |
5.7% |
| Urinary Tract Infection |
5.3% |
| Cellulitis |
4.9% |
| Pain |
4.9% |
| Arthralgia |
4.1% |
| Hypocalcaemia |
4.1% |
| Musculoskeletal Pain |
3.7% |
| Skin Reaction |
3.7% |
| Neck Pain |
3.3% |
| Pruritus |
3.3% |
| Stress Fracture |
3.3% |
| Blood Parathyroid Hormone Increased |
2.9% |
| Bone Pain |
2.9% |
| Inappropriate Schedule Of Drug Administration |
2.9% |
| Onychoclasis |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.5% |
| Osteoporosis |
17.5% |
| Rheumatoid Arthritis |
12.6% |
| Hypertension |
6.3% |
| Pain |
4.1% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Drug Use For Unknown Indication |
2.2% |
| Vitamin Supplementation |
2.2% |
| Atrial Fibrillation |
2.0% |
| Depression |
1.8% |
| Cardiac Disorder |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Asthma |
1.4% |
| Bone Disorder |
1.4% |
| Bladder Spasm |
1.3% |
| Fibromyalgia |
1.3% |
| Glaucoma |
1.3% |
| Hypothyroidism |
1.3% |
| Migraine |
1.3% |
| Blood Cholesterol Increased |
1.2% |
|
| Weight Decreased |
11.9% |
| Pain In Extremity |
10.7% |
| Rib Fracture |
7.1% |
| Retinal Detachment |
6.0% |
| Vomiting |
6.0% |
| Drug Ineffective |
4.8% |
| Nausea |
4.8% |
| Oedema Peripheral |
4.8% |
| Pruritus |
4.8% |
| Circulatory Collapse |
3.6% |
| Dyspnoea |
3.6% |
| Emotional Distress |
3.6% |
| Intentional Drug Misuse |
3.6% |
| Muscle Contractions Involuntary |
3.6% |
| Osteoporosis |
3.6% |
| Pelvic Fracture |
3.6% |
| Petechiae |
3.6% |
| Speech Disorder |
3.6% |
| Urosepsis |
3.6% |
| Weight Increased |
3.6% |
|
| Interacting |
| Crohn's Disease |
40.0% |
| Osteoporosis |
40.0% |
| Rosacea |
20.0% |
|
| Sciatica |
50.0% |
| Skin Haemorrhage |
50.0% |
|
